TY  - JOUR
AU  - Amat-Santos, Ignacio J
AU  - Santos-Martinez, Sandra
AU  - López-Otero, Diego
AU  - Nombela-Franco, Luis
AU  - Gutiérrez-Ibanes, Enrique
AU  - Del Valle, Raquel
AU  - Muñoz-García, Erika
AU  - Jiménez-Diaz, Víctor A
AU  - Regueiro, Ander
AU  - González-Ferreiro, Rocío
AU  - Benito, Tomás
AU  - Sanmartin-Pena, Xoan Carlos
AU  - Catalá, Pablo
AU  - Rodríguez-Gabella, Tania
AU  - Delgado-Arana, Jose Raúl
AU  - Carrasco-Moraleja, Manuel
AU  - Ibañez, Borja
AU  - San Román, J Alberto
PY  - 2020
DO  - 10.1016/j.jacc.2020.05.040
UR  - http://hdl.handle.net/10668/15657
T2  - Journal of the American College of Cardiology
AB  - Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory-syndrome coronavirus-2 that interfaces with the renin-angiotensin-aldosterone system (RAAS) through angiotensin-converting enzyme 2. This interaction has been proposed as a...
LA  - en
KW  - COVID-19
KW  - SARS-CoV-2
KW  - renin-angiotensin
KW  - transcatheter aortic valve replacement
KW  - Aged
KW  - Aged, 80 and over
KW  - Angiotensin-Converting Enzyme Inhibitors
KW  - Betacoronavirus
KW  - COVID-19
KW  - Coronavirus Infections
KW  - Female
KW  - Humans
KW  - Male
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Ramipril
KW  - Randomized Controlled Trials as Topic
KW  - Risk Factors
KW  - SARS-CoV-2
KW  - Spain
TI  - Ramipril in High-Risk Patients With COVID-19.
TY  - research article
VL  - 76
ER  -